Brief: EQL Pharma Q2 EBITDA at SEK 0.1 mln

EQL Pharma AB

21/08/2017 07:41

Aug 21 (Reuters) - EQL PHARMA AB  EQL.ST  
    * CONSOLIDATED SALES FOR Q2 AMOUNTED TO SEK 6.7 (4.6) 
MILLION 
    * EBITDA FOR Q2 AMOUNTED TO SEK 0.1 (0.5) MILLION 
 
Source text for Eikon:  ID:nWkr1Nsv7P  
Further company coverage:  EQL.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))